| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Vitamin D and Health in the 21st Century: an Update |
1 From the Department of Biochemistry and Division of Biomedical Sciences, University of California, Riverside, CA
ABSTRACT
New knowledge of the biological and clinical importance of the steroid hormone 1
,25-dihydroxyvitamin D3 [1,25(OH)2D3] and its receptor, the vitamin D receptor (VDR), has resulted in significant contributions to good bone health. However, worldwide reports have highlighted a variety of vitamin D insufficiency and deficiency diseases. Despite many publications and scientific meetings reporting advances in vitamin D science, a disturbing realization is growing that the newer scientific and clinical knowledge is not being translated into better human health. Over the past several decades, the biological sphere of influence of vitamin D3, as defined by the tissue distribution of the VDR, has broadened at least 9-fold from the target organs required for calcium homeostasis (intestine, bone, kidney, and parathyroid). Now, research has shown that the pluripotent steroid hormone 1,25(OH)2D3 initiates the physiologic responses of 
36 cell types that possess the VDR. In addition to the kidney's endocrine production of circulating 1,25(OH)2D3, researchers have found a paracrine production of this steroid hormone in 10 extrarenal organs. This article identifies the fundamentals of the vitamin D endocrine system, including its potential for contributions to good health in 5 physiologic arenas in which investigators have clearly documented new biological actions of 1,25(OH)2D3 through the VDR. As a consequence, the nutritional guidelines for vitamin D3 intake (defined by serum hydroxyvitamin D3 concentrations) should be reevaluated, taking into account the contributions to good health that all 36 VDR target organs can provide.
This article has been cited by other articles:
|
|
 |
|
  B. J. Nonnecke, T. A. Reinhardt, and W. R. Waters Short communication: The preruminant calf as a model for characterizing the effects of vitamin D status in the neonate J Dairy Sci, November 1, 2009; 92(11): 5692 - 5696. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. L. Martin, A. J. McKnight, C. C. Patterson, D. M. Sadlier, A. P. Maxwell, and The Warren 3/UK GoKinD Study Group A rare haplotype of the vitamin D receptor gene is protective against diabetic nephropathy Nephrol. Dial. Transplant., September 27, 2009; (2009) gfp515v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. NITTKE, E. KALLAY, T. MANHARDT, and H. S. CROSS Parallel Elevation of Colonic 1,25-Dihydroxyvitamin D3 Levels and Apoptosis in Female Mice on a Calcium-deficient Diet Anticancer Res, September 1, 2009; 29(9): 3727 - 3732. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. T. Mizwicki and A. W. Norman The Vitamin D Sterol-Vitamin D Receptor Ensemble Model Offers Unique Insights into Both Genomic and Rapid-Response Signaling Sci. Signal., June 16, 2009; 2(75): re4 - re4. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. D. Crew, E. Shane, S. Cremers, D. J. McMahon, D. Irani, and D. L. Hershman High Prevalence of Vitamin D Deficiency Despite Supplementation in Premenopausal Women With Breast Cancer Undergoing Adjuvant Chemotherapy J. Clin. Oncol., May 1, 2009; 27(13): 2151 - 2156. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. Goodwin Vitamin D in Cancer Patients: Above All, Do No Harm J. Clin. Oncol., May 1, 2009; 27(13): 2117 - 2119. [Full Text] [PDF]
|
|
|
|
 |
|
 A. W Norman A vitamin D nutritional cornucopia: new insights concerning the serum 25-hydroxyvitamin D status of the US population Am. J. Clinical Nutrition, December 1, 2008; 88(6): 1455 - 1456. [Full Text] [PDF]
|
|
|
|
|
|
A. Prentice, G. R Goldberg, and I. Schoenmakers Vitamin D across the lifecycle: physiology and biomarkers Am. J. Clinical Nutrition, August 1, 2008; 88(2): 500S - 506S. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
